Biogen Idec outlines strategy ahead of management re-shuffle
This article was originally published in Scrip
Executive Summary
Biogen Idec's CEO and president James Mullen laid out the company's plans for 2010 and beyond at the JP Morgan Healthcare Conference on January 12th, safe in the knowledge that he will not be presiding over the doubt-ridden company.